DK0600873T3 - Terapeutisk virksom topisk anvendelse af ST1435 - Google Patents

Terapeutisk virksom topisk anvendelse af ST1435

Info

Publication number
DK0600873T3
DK0600873T3 DK91912052.7T DK91912052T DK0600873T3 DK 0600873 T3 DK0600873 T3 DK 0600873T3 DK 91912052 T DK91912052 T DK 91912052T DK 0600873 T3 DK0600873 T3 DK 0600873T3
Authority
DK
Denmark
Prior art keywords
therapeutically effective
topical application
effective topical
skin
blood
Prior art date
Application number
DK91912052.7T
Other languages
English (en)
Inventor
Alfred Moo-Young
Ana Zepeda-Ortega
Horacio Bruno Croxatto
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Application granted granted Critical
Publication of DK0600873T3 publication Critical patent/DK0600873T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK91912052.7T 1990-06-01 1991-05-24 Terapeutisk virksom topisk anvendelse af ST1435 DK0600873T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53221590A 1990-06-01 1990-06-01

Publications (1)

Publication Number Publication Date
DK0600873T3 true DK0600873T3 (da) 1997-05-20

Family

ID=24120850

Family Applications (2)

Application Number Title Priority Date Filing Date
DK96201585T DK0754456T3 (da) 1990-06-01 1991-05-24 Forberedelse af sammensætninger der omfatter ST1435 til topisk anvendelse
DK91912052.7T DK0600873T3 (da) 1990-06-01 1991-05-24 Terapeutisk virksom topisk anvendelse af ST1435

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK96201585T DK0754456T3 (da) 1990-06-01 1991-05-24 Forberedelse af sammensætninger der omfatter ST1435 til topisk anvendelse

Country Status (10)

Country Link
US (1) US5651973A (da)
EP (3) EP1093816A3 (da)
JP (1) JP2625254B2 (da)
AT (2) ATE151977T1 (da)
CA (1) CA2083404C (da)
DE (2) DE69125855T2 (da)
DK (2) DK0754456T3 (da)
ES (2) ES2099747T3 (da)
GR (1) GR3023312T3 (da)
WO (1) WO1991018570A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69125855T2 (de) * 1990-06-01 1997-07-31 The Population Council, New York, N.Y. Therapeutisch wirksame, örtliche anwendung von st1435
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
AU2003235716A1 (en) * 2002-01-17 2003-07-30 Lts Lohmann Therapie-Systeme Ag Method for neutralizing or recycling carrier materials for film-like coatings
GB2389793A (en) * 2002-06-18 2003-12-24 Euro Celtique Sa Transdermal delivery system
US20040057983A1 (en) 2002-09-25 2004-03-25 David Schmidt Biomolecular wearable apparatus
BRPI0617294B8 (pt) 2005-10-12 2021-05-25 Besins Healthcare Lu Sarl composição farmacêutica em gel hidroalcóolico e uso de testosterona
US8602961B2 (en) * 2008-05-15 2013-12-10 Lifewave Products Llc Apparatus and method of stimulating elevation of glutathione levels in a subject
WO2010019365A1 (en) * 2008-08-12 2010-02-18 Optimer, Inc. Method of reducing the distortion of the electromagnetic field
JP6082249B2 (ja) 2009-12-17 2017-02-15 ザ・ポピュレイション・カウンシル，インコーポレイテッド 経皮ゲル製剤
US10322063B2 (en) 2013-03-19 2019-06-18 Genovus Biotechnologies Inc. Muscle optimization device and method
US10888707B2 (en) 2013-03-19 2021-01-12 Genovus Biotechnologies Inc. Muscle optimization device and method
BR112017009594A2 (pt) 2014-11-25 2018-04-03 Buckman Laboratories Int Inc método para limpar ou condicionar um pano, correia, feltro ou tela utilizada em processo de fabricação de papel ou de fabricação polpa, método para limpar ou condicionar feltro de prensa fabricação de papel utilizado em um processo de fabricação de papel e método para limpar ou condicionar um substrato

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543245C3 (de) * 1965-11-26 1974-07-18 Merck Patent Gmbh, 6100 Darmstadt 16-Methy len-19-norprogesteronderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
NL6902314A (da) * 1969-02-13 1970-08-17
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4834978A (en) * 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
CH674618A5 (da) * 1987-04-02 1990-06-29 Ciba Geigy Ag
WO1990004397A1 (de) * 1988-10-27 1990-05-03 Schering Aktiengesellschaft Berlin Und Bergkamen Mittel zur transdermalen applikation enthaltend gestoden
WO1991018572A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Device for transdermal administration of drugs
DE69125855T2 (de) * 1990-06-01 1997-07-31 The Population Council, New York, N.Y. Therapeutisch wirksame, örtliche anwendung von st1435
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices

Also Published As

Publication number Publication date
GR3023312T3 (en) 1997-08-29
DK0754456T3 (da) 2002-11-11
JPH07502253A (ja) 1995-03-09
DE69133077D1 (de) 2002-08-29
EP0600873A4 (en) 1993-09-02
CA2083404C (en) 2001-02-20
ATE151977T1 (de) 1997-05-15
DE69125855T2 (de) 1997-07-31
JP2625254B2 (ja) 1997-07-02
ATE220912T1 (de) 2002-08-15
WO1991018570A1 (en) 1991-12-12
DE69133077T2 (de) 2002-11-07
ES2180690T3 (es) 2003-02-16
EP0754456A2 (en) 1997-01-22
CA2083404A1 (en) 1991-12-02
EP1093816A2 (en) 2001-04-25
US5651973A (en) 1997-07-29
EP0600873B1 (en) 1997-04-23
EP0600873A1 (en) 1994-06-15
EP1093816A3 (en) 2003-10-22
DE69125855D1 (de) 1997-05-28
ES2099747T3 (es) 1997-06-01
EP0754456B1 (en) 2002-07-24
EP0754456A3 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
DK0600873T3 (da) Terapeutisk virksom topisk anvendelse af ST1435
FI940807A0 (fi) Peptidejä, joilla on kasvuhormonia vapauttavaa aktiivisuutta
DE69518729D1 (de) Stickstoffoxyd abgebendes präparat zur behandlung von analen erkrankungen
DK0682514T3 (da) Anvendelse af lokalanæstetiske midler til fremstilling af et lægmiddel til behandling af bronchial astma
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
TR200002179T2 (tr) Kristalin teriparatid.
ATE107517T1 (de) Transdermales therapeutisches mittel.
SE8903914D0 (sv) Oral composition for the treatment of inflammatory bowel diseases
DK0378086T3 (da) Anvendelse af det aktive stof azelastin til bekæmpelse af psoriasis-sygdomme
ATE128622T1 (de) Behandlungsmittel.
IT8867534A0 (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
IT1057132B (it) Bendaggio stratificato per la somministrazione di scopolamina per via transdermica
DK1383540T3 (da) Fremgangsmdåer og farmaceutiske sammensætninger til sårheling
AR219561A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-piperidino-6,7-dialcoxi-ftalazina utiles como agentes terapeuticos
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
IT1254521B (it) Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare
DK0509120T3 (da) Topisk anvendelse af glycosaminoglycaner til forebyggelse og behandling af sygdomme, der påvirker det cervikale vaginale område
NL7804192A (nl) Cyclohexaancarbonzuur en de derivaten hiervan, evenals de toepassing van deze stoffen als therapeutisch mid- del.
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
ATE435023T1 (de) Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
DK295378A (da) Fremgangsmaade til fremstilling af terapeutisk virksomme diarylalkylaminer
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
SE8306384L (sv) Farmaceutisk komposition
LV10952A (lv) Terapeitiski aktivi fluoraizvietoti benzimidazoli to iegusanas panemieni mineto terapeitiski aktivo fluoraizvietoto benzimidazolu pielietojums
SU1095491A1 (ru) Средство дл лечени кардиалгий и легких форм ишемической болезни сердца "мебикар